|
1
|
Galluzzi L, Pietrocola F, Bravo-San Pedro
JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J,
Gewirtz DA, Karantza V, et al: Autophagy in malignant
transformation and cancer progression. EMBO J. 34:856–880. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ropolo A, Bagnes CI, Molejon MI, Lo Re A,
Boggio V, Gonzalez CD and Vaccaro MI: Chemotherapy and
autophagy-mediated cell death in pancreatic cancer cells.
Pancreatology. 12:1–7. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang A and Kimmelman AC: Inhibition of
autophagy attenuates pancreatic cancer growth independent of
TP53/TRP53 status. Autophagy. 10:1683–1684. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Donohue E, Thomas A, Maurer N, Manisali I,
Zeisser-Labouebe M, Zisman N, Anderson HJ, Ng SS, Webb M, Bally M,
et al: The autophagy inhibitor verteporfin moderately enhances the
antitumor activity of gemcitabine in a pancreatic ductal
adenocarcinoma model. J Cancer. 4:585–596. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hashimoto D, Bläuer M, Hirota M, Ikonen
NH, Sand J and Laukkarinen J: Autophagy is needed for the growth of
pancreatic adenocarcinoma and has a cytoprotective effect against
anticancer drugs. Eur J Cancer. 50:1382–1390. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Papademetrio DL, Cavaliere V, Simunovich
T, Costantino S, Campos MD, Lombardo T, Kaiser CM and Alvarez E:
Interplay between autophagy and apoptosis in pancreatic tumors in
response to gemcitabine. Target Oncol. 9:123–134. 2014. View Article : Google Scholar
|
|
7
|
Yang S, Wang X, Contino G, Liesa M, Sahin
E, Ying H, Bause A, Li Y, Stommel JM, Dell'antonio G, et al:
Pancreatic cancers require autophagy for tumor growth. Genes Dev.
25:717–729. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Neoptolemos JP, Stocken DD, Bassi C,
Ghaneh P, Cunningham D, Goldstein D, Padbury R, Moore MJ, Gallinger
S, Mariette C, et al; European Study Group for Pancreatic Cancer.
Adjuvant chemotherapy with fluorouracil plus folinic acid vs
gemcitabine following pancreatic cancer resection: A randomized
controlled trial. JAMA. 304:1073–1081. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wolpin BM, Rubinson DA, Wang X, Chan JA,
Cleary JM, Enzinger PC, Fuchs CS, McCleary NJ, Meyerhardt JA, Ng K,
et al: Phase II and pharmacodynamic study of autophagy inhibition
using hydroxychloroquine in patients with metastatic pancreatic
adenocarcinoma. Oncologist. 19:637–638. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schmukler E, Kloog Y and Pinkas-Kramarski
R: Ras and autophagy in cancer development and therapy. Oncotarget.
5:577–586. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eser S, Schnieke A, Schneider G and Saur
D: Oncogenic KRAS signalling in pancreatic cancer. Br J Cancer.
111:817–822. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Morgan MJ, Gamez G, Menke C, Hernandez A,
Thorburn J, Gidan F, Staskiewicz L, Morgan S, Cummings C, Maycotte
P, et al: Regulation of autophagy and chloroquine sensitivity by
oncogenic RAS in vitro is context-dependent. Autophagy.
10:1814–1826. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Settembre C and Ballabio A: TFEB regulates
autophagy: An integrated coordination of cellular degradation and
recycling processes. Autophagy. 7:1379–1381. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Settembre C, Di Malta C, Polito VA, Garcia
Arencibia M, Vetrini F, Erdin S, Erdin SU, Huynh T, Medina D,
Colella P, et al: TFEB links autophagy to lysosomal biogenesis.
Science. 332:1429–1433. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Settembre C, Zoncu R, Medina DL, Vetrini
F, Erdin S, Erdin S, Huynh T, Ferron M, Karsenty G, Vellard MC, et
al: A lysosome-to-nucleus signalling mechanism senses and regulates
the lysosome via mTOR and TFEB. EMBO J. 31:1095–1108. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Argani P, Laé M, Hutchinson B, Reuter VE,
Collins MH, Perentesis J, Tomaszewski JE, Brooks JS, Acs G, Bridge
JA, et al: Renal carcinomas with the t(6;11)(p21;q12):
Clinicopathologic features and demonstration of the specific
alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA
PCR. Am J Surg Pathol. 29:230–240. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kimura S, Noda T and Yoshimori T:
Dissection of the autophagosome maturation process by a novel
reporter protein, tandem fluorescent-tagged LC3. Autophagy.
3:452–460. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Werner K, Lademann F, Thepkaysone ML,
Jahnke B, Aust DE, Kahlert C, Weber G, Weitz J, Grützmann R and
Pilarsky C: Simultaneous gene silencing of KRAS and anti-apoptotic
genes as a multitarget therapy. Oncotarget. 26:3984–3992. 2016.
|
|
19
|
Rückert F, Samm N, Lehner AK, Saeger HD,
Grützmann R and Pilarsky C: Simultaneous gene silencing of Bcl-2,
XIAP and Survivin re-sensitizes pancreatic cancer cells towards
apoptosis. BMC Cancer. 10:3792010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Welsch T, Younsi A, Disanza A, Rodriguez
JA, Cuervo AM, Scita G and Schmidt J: Eps8 is recruited to
lysosomes and subjected to chaperone-mediated autophagy in cancer
cells. Exp Cell Res. 316:1914–1924. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Furuta S, Hidaka E, Ogata A, Yokota S and
Kamata T: Ras is involved in the negative control of autophagy
through the class I PI3-kinase. Oncogene. 23:3898–3904. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim SE, Park HJ, Jeong HK, Kim MJ, Kim M,
Bae ON and Baek SH: Autophagy sustains the survival of human
pancreatic cancer PANC-1 cells under extreme nutrient deprivation
conditions. Biochem Biophys Res Commun. 463:205–210. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Haq R and Fisher DE: Biology and clinical
relevance of the micropthalmia family of transcription factors in
human cancer. J Clin Oncol. 29:3474–3482. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Perera RM, Stoykova S, Nicolay BN, Ross
KN, Fitamant J, Boukhali M, Lengrand J, Deshpande V, Selig MK,
Ferrone CR, et al: Transcriptional control of autophagy-lysosome
function drives pancreatic cancer metabolism. Nature. 524:361–365.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Son J, Lyssiotis CA, Ying H, Wang X, Hua
S, Ligorio M, Perera RM, Ferrone CR, Mullarky E, Shyh-Chang N, et
al: Glutamine supports pancreatic cancer growth through a
KRAS-regulated metabolic pathway. Nature. 496:101–105. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ying H, Kimmelman AC, Lyssiotis CA, Hua S,
Chu GC, Fletcher-Sananikone E, Locasale JW, Son J, Zhang H, Coloff
JL, et al: Oncogenic Kras maintains pancreatic tumors through
regulation of anabolic glucose metabolism. Cell. 149:656–670. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bryant KL, Mancias JD, Kimmelman AC and
Der CJ: KRAS: Feeding pancreatic cancer proliferation. Trends
Biochem Sci. 39:91–100. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Commisso C, Davidson SM, Soydaner-Azeloglu
RG, Parker SJ, Kamphorst JJ, Hackett S, Grabocka E, Nofal M, Drebin
JA, Thompson CB, et al: Macropinocytosis of protein is an amino
acid supply route in Ras-transformed cells. Nature. 497:633–637.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo JY, Chen HY, Mathew R, Fan J,
Strohecker AM, Karsli-Uzunbas G, Kamphorst JJ, Chen G, Lemons JM,
Karantza V, et al: Activated Ras requires autophagy to maintain
oxidative metabolism and tumorigenesis. Genes Dev. 25:460–470.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo JY, Xia B and White E:
Autophagy-mediated tumor promotion. Cell. 155:1216–1219. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Moore PS, Sipos B, Orlandini S, Sorio C,
Real FX, Lemoine NR, Gress T, Bassi C, Klöppel G, Kalthoff H, et
al: Genetic profile of 22 pancreatic carcinoma cell lines. Analysis
of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch. 439:798–802.
2001. View Article : Google Scholar
|
